JLK-Winew Signs MOU for Stroke Content Production

Kim Dong-min, CEO of JLK (left), and Hwang Bo-yul, CEO of WeNew, are posing for a commemorative photo. (Photo by JLK)

[Asia Economy Reporter Chunhee Lee] Medical artificial intelligence (AI) company JLK and healthcare knowledge content company Winu announced on the 21st that they have signed a business cooperation MOU for the 'AI-based medical solution and patient-customized stroke content production project.'

The event held at the JLK headquarters in Gangnam-gu, Seoul was attended by CEO Dongmin Kim and Chief Medical Officer (CMO) Euisun Ryu from JLK, and CEO Yul Hwangbo and Chief Technology Officer (CTO) Hyoseong Cha from Winu, along with other officials from both companies.

Through this MOU, the two companies aim to increase social understanding of the medical AI field, provide accurate medical information with added expertise on stroke, a frequently occurring severe disease, and jointly promote future patient-centered stroke prognosis prediction information delivery services.

JLK, the first AI company to be listed in the field, is conducting business domestically and internationally centered on the stroke full-cycle solution ‘MEDIHUB STROKE,’ which analyzes brain images such as computed tomography (CT) and magnetic resonance imaging (MRI) to provide stroke diagnosis and treatment plans. The company has obtained various global certifications including Japan, Thailand, Malaysia, and European CE, while strengthening its technological capabilities and business capacity through the largest number of medical AI clinic project orders and research presentations at international stroke conferences.

Winu is a healthcare content company founded by CEO Yul Hwangbo, an internal medicine specialist who previously worked in the AI business team at the National Cancer Center. The company aims to deliver accurate medical information and healthcare content tailored to users’ perspectives directly from medical professionals. Recently, it has been promoting global expansion projects, including participation in the World Health Organization (WHO) official content production project.

JLK CEO Dongmin Kim said, “This agreement will be a great opportunity to promote stroke prevention education and various related services in the B2C market,” adding, “Through close collaboration with Winu, we will enhance public and user understanding of AI medical technology, which is often perceived as a difficult field, and help people feel that this technology is close to them.”

Winu CEO Yul Hwangbo also stated, “We will produce customized information on stroke, which can cause fatal disabilities, with Winu’s expertise, and contribute to the expansion and activation of the AI-based medical service market through cooperation with JLK.”

This content was produced with the assistance of AI translation services.